d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Gallium 68-DOTATATE (Primary) ; Fludeoxyglucose F-18
- Indications Heart disorders; Sarcoidosis
- Focus Diagnostic use
- 23 Aug 2018 Last checked against ClinicalTrials.gov record.
- 14 Aug 2018 Status changed from not yet recruiting to recruiting.
- 14 Jun 2018 New trial record